Pentavalent Vaccine Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Vaccines are biological preparations that provide immunity against a specific or number of diseases. Pentavalent vaccine is a combination of five vaccines. It provides immunity to children against five potentially fatal diseases: diphtheria, pertussis, tetanus, hepatitis B, and hemophilius influenza type b. Governments of several countries such as India have decided to include the vaccine in the national immunization schedule. This vaccine can be given to any child aged from 6 weeks to 1 year.
The global pentavalent vaccine market is projected to grow at a significant rate during the forecast period. According to the World Health Organization, hemophilius influenza type b (Hib) is one of the leading causes of childhood pneumonia and meningitis. Hib caused around 8.1 million illnesses globally in 2000. Hence, high incidence rate of the disease is one of the major factors fueling the growth of the global pentavalent vaccine market. Implementation of universal immunization program, rise in awareness about child care, and high efficiency are the other factors likely to propel the global market during the forecast period. Furthermore, less pricks to children and protection against five diseases, government initiatives to reduce incidence of the diseases, entry of new vaccine developers, and robust R&D are factors expected to fuel the growth of the global market from 2017 to 2025. Stringent government regulation regarding efficacy and safety and lack of coverage area can act as major restraints of the global pentavalent vaccine market during the forecast period.
The global pentavalent vaccine market can be segmented based on formulation type, distribution channel, and region. In terms of formulation type, the global market can be divided into lyophilized and liquid. The liquid segment is expected to hold a significant share during the forecast period, as only liquid formulation is used in several regions such as India based on immunization program. Based on distribution channel, the global pentavalent vaccine market can be categorized into retail pharmacies, hospital pharmacies, and e-commerce.
Geographically, the global pentavalent vaccine market can be segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America is anticipated to dominate the global market, accounting for the largest share during the forecast period. Surge in investment by government and public sector and government initiatives to make the region disease free are the factors propelling the pentavalent vaccine market in North America. Furthermore, adherence to immunization program and high health care expenditure are the factors boosting market growth in the region. Europe is expected to hold a significant share of the global market due to increased awareness and development of childcare programs. The market in Asia Pacific is anticipated to register faster growth rate during the forecast period. High prevalence of the disease, entry of market players in countries such as India and China, rise in awareness among people, increased funding research activities, and compulsory and free immunization programs by governments are the factors driving the market in the region.
Key players have adopted strategies such as geographical expansion, safety and efficacy of vaccines, and cost-effectiveness to sustain their positions in the global pentavalent vaccine market. Major players operating in the global market are Serum Institute of India, Panacea Drugs Pvt. Ltd., Shantha Biotechnics, Biological E. Ltd., and Novartis AG, among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Vaccines
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017